المضادات الحيوية التي حددها الذكاء الاصطناعي

The field of drug discovery is transforming in the advent of artificial intelligence. At the MIT Abdul Latif Jameel Clinic for Machine Learning and Health (MIT Jameel Clinic), co-principal investigators Jim Collins and Regina Barzilay, have leveraged AI technology for the discovery of two antibiotics, halicin and abaucin, the latter of which is effective in targeting the bacterial pathogen Acinetobacter baumannii.

‍